Assess whether the AI buy is high-risk and under-evaluated (5fbdcd)

Situation

The AI buy is sits with contracting officer's technical representative because an AI RFP that treats accuracy as the only evaluation factor hit a Medicare contractor SIU pack. Evidence is clinical-trial site anomaly report; write the US Federal AI Governance Vendor Risk option that extract can carry.

Decision

Contracting officer's technical representative in a Medicare contractor SIU pack must choose Pursue / Pursue with conditions / Partner / No-bid using clinical-trial site anomaly report after an AI RFP that treats accuracy as the only evaluation factor.

Hypotheses to test

• Authorize Pursue now; clinical-trial site anomaly report already has the discriminator after an AI RFP that treats accuracy as the only evaluation factor.
• Keep Pursue with conditions in force until clinical-trial site anomaly report is completed after an AI RFP that treats accuracy as the only evaluation factor for contracting officer's technical representative.
• Treat clinical-trial site anomaly report as Partner because both readings appear after an AI RFP that treats accuracy as the only evaluation factor.
• Refuse a US Federal close: contracting officer's technical representative does not have the page the AI buy is turns on in clinical-trial site anomaly report.

Analysis required

• Map FAR, Section L/M, and evaluator priorities in clinical-trial site anomaly report after an AI RFP that treats accuracy as the only evaluation factor.
• Name the evaluation right contracting officer's technical representative would forfeit by rushing.
• Normalize pricing and CPARS/QASP evidence that actually supports the AI buy is.
• For this US Federal AI Governance Vendor Risk file, read clinical-trial site anomaly report against an AI RFP that treats accuracy as the only evaluation factor and write the one fact that would move the AI buy is for contracting officer's technical representative.

Recommendation

Choose Pursue / Pursue with conditions / Partner / No-bid on this US Federal / AI Governance Vendor Risk packet (clinical-trial site anomaly report after an AI RFP that treats accuracy as the only evaluation factor). Lead with the US Federal option clinical-trial site anomaly report can support after an AI RFP that treats accuracy as the only evaluation factor, then the two facts that force it, then the Monday action for contracting officer's technical representative in a Medicare contractor SIU pack.